# Developing and Testing the Opioid Rapid Response System

> **NIH NIH R41** · REAL PREVENTION, LLC · 2021 · $52,000

## Abstract

The goal of this project is to prevent deaths from opioid overdoses through developing and
commercializing the Opioid Rapid Response System (ORRS). This system is designed to reduce the cost
of the opioid epidemic by developing standardized and effective procedures for recruiting and training
citizen responders to use the PulsePoint app to administer life-saving naloxone/Narcan. This i-Corps
supplement will assess the commercialization potential for ORRS and develop a plan for dissemination.

## Key facts

- **NIH application ID:** 10304577
- **Project number:** 3R41DA053078-01S2
- **Recipient organization:** REAL PREVENTION, LLC
- **Principal Investigator:** Michael Hecht
- **Activity code:** R41 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $52,000
- **Award type:** 3
- **Project period:** 2020-09-30 → 2021-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10304577

## Citation

> US National Institutes of Health, RePORTER application 10304577, Developing and Testing the Opioid Rapid Response System (3R41DA053078-01S2). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10304577. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*